Evidence map›Paper›PMID 40892880›Full record

ArticlePLoS pathogens2025

Identification of a Kingella kingae factor H binding protein that is the major determinant of serum resistance.

Kevin A Hernandez, Eric A Porsch, Vanessa L Muñoz, Joseph W St Geme Iii

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. It is time to have a molecular test for diagnosingJournal of clinical microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kevin A HernandezUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
Eric A PorschDepartment of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
Vanessa L MuñozDepartment of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
Joseph W St Geme IiiUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.ORCID 0000-0002-6787-9510

Funding

Virulence mechanisms in the emerging pathogen Kingella kingaeR01AI121015 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI ST. GEME, JOSEPH W. · 2016 to 2020
$2.1M
Pathogenicity of the emerging pathogen Kingella kingaeR01AI172841 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI Joseph W. St. Geme · 2023 to 2026
$1.8M
NIAID NIH HHS R01 AI121015NIAID NIH HHS R01 AI172841
6 · The paper itself

Abstract

Kingella kingae is a Gram-negative bacterium that has emerged as a leading cause of invasive disease in children between 6 months and 4 years of age. K. kingae initiates infection by colonizing the oropharynx, then breaches the oropharyngeal epithelium, enters the bloodstream, and disseminates to distant sites to cause disease, including osteomyelitis, septic arthritis, and endocarditis. To survive in the bloodstream and disseminate to sites of invasive disease, K. kingae produces a polysaccharide capsule and an exopolysaccharide that inhibit opsonin deposition and mediate resistance to complement-mediated serum killing. However, elimination of these extracellular polysaccharides only partially reduces K. kingae survival in human serum, suggesting that additional factors contribute to serum resistance. In this study, we found that K. kingae binds human factor H (FH), a negative regulator of the alternative complement pathway. In experiments using rat serum as a source of complement, we observed that K. kingae was able to utilize human FH to resist killing. Introduction of exogenous human FH into the juvenile rat infection model of K. kingae disease enhanced virulence in vivo, demonstrating the importance of FH binding in the pathogenesis of disease. Far-western blot analysis identified a 37-kDa outer membrane protein designated KK02920 that was responsible for FH binding and enhanced virulence in vivo in the presence of human FH. Loss of KK02920 virtually abrogated serum resistance, indicating that KK02920 is the major determinant of K. kingae serum resistance. Additional analysis revealed the presence of KK02920 across a collection of serum-resistant invasive and carrier K. kingae isolates, all of which can utilize human FH to resist complement-mediated killing. This work demonstrates the importance of a complement-regulator binding protein as a major mechanism of serum resistance in an encapsulated organism.

Indexed as

Bacterial ProteinsBlood Bactericidal ActivityComplement Factor HKingella kingaeNeisseriaceae InfectionsAnimalsHumansRatsBacterial ProteinsComplement Factor H

Identifiers

PMID40892880
PMCPMC12416846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.